Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Myomo (MYO) Research & Development (2016 - 2025)

Myomo's Research & Development history spans 10 years, with the latest figure at $1.5 million for Q3 2025.

  • For Q3 2025, Research & Development rose 22.32% year-over-year to $1.5 million; the TTM value through Sep 2025 reached $6.9 million, up 68.17%, while the annual FY2024 figure was $4.8 million, 81.0% up from the prior year.
  • Research & Development reached $1.5 million in Q3 2025 per MYO's latest filing, down from $2.0 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $2.0 million in Q2 2025 to a low of $476991.0 in Q1 2023.
  • Average Research & Development over 5 years is $934997.0, with a median of $717256.0 recorded in 2023.
  • Peak YoY movement for Research & Development: plummeted 36.56% in 2022, then skyrocketed 100.47% in 2024.
  • A 5-year view of Research & Development shows it stood at $787628.0 in 2021, then plummeted by 36.56% to $499674.0 in 2022, then surged by 75.72% to $878006.0 in 2023, then soared by 77.64% to $1.6 million in 2024, then decreased by 2.05% to $1.5 million in 2025.
  • Per Business Quant, the three most recent readings for MYO's Research & Development are $1.5 million (Q3 2025), $2.0 million (Q2 2025), and $1.8 million (Q1 2025).